Prediction and Validation of a Druggable Site on Virulence Factor of Drug Resistant Burkholderia cenocepacia*.


Journal

Chemistry (Weinheim an der Bergstrasse, Germany)
ISSN: 1521-3765
Titre abrégé: Chemistry
Pays: Germany
ID NLM: 9513783

Informations de publication

Date de publication:
16 Jul 2021
Historique:
received: 21 01 2021
pubmed: 27 3 2021
medline: 21 7 2021
entrez: 26 3 2021
Statut: ppublish

Résumé

Burkholderia cenocepacia is an opportunistic Gram-negative bacterium that causes infections in patients suffering from chronic granulomatous diseases and cystic fibrosis. It displays significant morbidity and mortality due to extreme resistance to almost all clinically useful antibiotics. The bacterial lectin BC2L-C expressed in B. cenocepacia is an interesting drug target involved in bacterial adhesion and subsequent deadly infection to the host. We solved the first high resolution crystal structure of the apo form of the lectin N-terminal domain (BC2L-C-nt) and compared it with the ones complexed with carbohydrate ligands. Virtual screening of a small fragment library identified potential hits predicted to bind in the vicinity of the fucose binding site. A series of biophysical techniques and X-ray crystallographic screening were employed to validate the interaction of the hits with the protein domain. The X-ray structure of BC2L-C-nt complexed with one of the identified active fragments confirmed the ability of the site computationally identified to host drug-like fragments. The fragment affinity could be determined by titration microcalorimetry. These structure-based strategies further provide an opportunity to elaborate the fragments into high affinity anti-adhesive glycomimetics, as therapeutic agents against B. cenocepacia.

Identifiants

pubmed: 33769626
doi: 10.1002/chem.202100252
pmc: PMC8360069
doi:

Substances chimiques

Lectins 0
Pharmaceutical Preparations 0
Virulence Factors 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

10341-10348

Subventions

Organisme : European Union's Horizon 2020 research and innovation program
ID : 765581
Organisme : ANR PIA Glyco@Alps
ID : ANR-15-IDEX-02
Organisme : Labex Arcane-CBH-EUR-GS
ID : ANR-17-EURE-0003
Organisme : Universita degli Studi di Milano
ID : CARE-CRUI
Organisme : Horizon 2020 Framework Programme
ID : Marie Skłodowska-Curie grant agreement No 765581
Organisme : LABoratoires d'EXcellence ARCANE
ID : ANR-17-EURE-0003

Informations de copyright

© 2021 The Authors. Chemistry - A European Journal published by Wiley-VCH GmbH.

Références

J Chem Inf Model. 2009 Feb;49(2):377-89
pubmed: 19434839
Molecules. 2020 Jan 07;25(2):
pubmed: 31936166
Nat Rev Microbiol. 2005 Feb;3(2):144-56
pubmed: 15643431
Chemistry. 2021 Jul 16;27(40):10341-10348
pubmed: 33769626
Acta Crystallogr D Biol Crystallogr. 2010 Apr;66(Pt 4):486-501
pubmed: 20383002
Proteins. 2005 Feb 15;58(3):735-46
pubmed: 15573375
Angew Chem Int Ed Engl. 2003 Feb 24;42(8):864-90
pubmed: 12596167
Nat Rev Drug Discov. 2009 Aug;8(8):661-77
pubmed: 19629075
Microbiology (Reading). 2009 Sep;155(Pt 9):2809-2817
pubmed: 19542002
Glycobiology. 2018 Dec 1;28(1):42-49
pubmed: 29087468
BMJ. 2013 Mar 11;346:f1493
pubmed: 23479660
Acta Crystallogr D Biol Crystallogr. 2011 Apr;67(Pt 4):235-42
pubmed: 21460441
Trends Biotechnol. 2016 Jun;34(6):483-495
pubmed: 26875976
Acta Crystallogr D Biol Crystallogr. 2011 Apr;67(Pt 4):355-67
pubmed: 21460454
Infect Immun. 2010 Oct;78(10):4088-100
pubmed: 20643851
Medicine (Baltimore). 2000 May;79(3):155-69
pubmed: 10844935
J Chem Theory Comput. 2016 Jan 12;12(1):281-96
pubmed: 26584231
Microbes Infect. 2004 Feb;6(2):221-8
pubmed: 15049333
J Antimicrob Chemother. 2002 Aug;50(2):265-9
pubmed: 12161410
Nucleic Acids Res. 2000 Jan 1;28(1):235-42
pubmed: 10592235
J Med Chem. 2004 Mar 25;47(7):1739-49
pubmed: 15027865
Proteins. 2008 Nov 15;73(3):765-83
pubmed: 18498103
Drug Discov Today. 2018 Jun;23(6):1258-1266
pubmed: 29522887
Structure. 2010 Jan 13;18(1):59-72
pubmed: 20152153
Acta Crystallogr D Biol Crystallogr. 2010 Feb;66(Pt 2):125-32
pubmed: 20124692
Acta Crystallogr D Biol Crystallogr. 2007 Jan;63(Pt 1):32-41
pubmed: 17164524
Angew Chem Int Ed Engl. 2017 Nov 27;56(48):15289-15293
pubmed: 28977722
Biophys J. 2008 Oct;95(7):3222-31
pubmed: 18599640
J Clin Microbiol. 1995 Apr;33(4):1001-4
pubmed: 7540623
FEMS Immunol Med Microbiol. 2003 Oct 15;38(3):181-91
pubmed: 14522453
J Biomol Screen. 2001 Dec;6(6):429-40
pubmed: 11788061
J Appl Microbiol. 2008 Jun;104(6):1539-51
pubmed: 18217926
J Chem Theory Comput. 2011 Feb 8;7(2):525-37
pubmed: 26596171
Glycobiology. 2010 Jan;20(1):87-98
pubmed: 19770128
Proteins. 2005 Dec 1;61(4):704-21
pubmed: 16231289
PLoS Pathog. 2011 Sep;7(9):e1002238
pubmed: 21909279
Biochem J. 2008 Apr 15;411(2):307-18
pubmed: 18215132

Auteurs

Kanhaya Lal (K)

Universita' degli Studi di Milano, Dipartimento di Chimica, via Golgi 19, I-20133, Milano, Italy.
Université Grenoble Alpes, CNRS, CERMAV, 38000, Grenoble, France.

Rafael Bermeo (R)

Universita' degli Studi di Milano, Dipartimento di Chimica, via Golgi 19, I-20133, Milano, Italy.
Université Grenoble Alpes, CNRS, CERMAV, 38000, Grenoble, France.

Jonathan Cramer (J)

University of Basel, Department of Pharmaceutical Sciences, Klingelbergstrasse 50, 4056, Basel, Switzerland.

Francesca Vasile (F)

Universita' degli Studi di Milano, Dipartimento di Chimica, via Golgi 19, I-20133, Milano, Italy.

Beat Ernst (B)

University of Basel, Department of Pharmaceutical Sciences, Klingelbergstrasse 50, 4056, Basel, Switzerland.

Anne Imberty (A)

Université Grenoble Alpes, CNRS, CERMAV, 38000, Grenoble, France.

Anna Bernardi (A)

Universita' degli Studi di Milano, Dipartimento di Chimica, via Golgi 19, I-20133, Milano, Italy.

Annabelle Varrot (A)

Université Grenoble Alpes, CNRS, CERMAV, 38000, Grenoble, France.

Laura Belvisi (L)

Universita' degli Studi di Milano, Dipartimento di Chimica, via Golgi 19, I-20133, Milano, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH